Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06659991 · ClinicalTrials.gov registry record · Early Phase 1

JIT: Effect of Pain on DT in TMD

A Early Phase 1 study of Temporomandibular Disorder (TMD), sponsored by University of Minnesota.

Recruiting
Registry status
Early Phase 1
Development phase
160
Enrollment target
1
Study location

NCT06659991 is a Early Phase 1 study of Temporomandibular Disorder (TMD) that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 160 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06659991, a Early Phase 1 study of Temporomandibular Disorder (TMD), is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
Early Phase 1
Development phase
160 participants
Enrollment target
1
Study location

Study Summary

Individuals with chronic temporomandibular disorder (TMD) pain are at increased risk for alcohol-related consequences compared to those without pain, and growing evidence suggests pain is a potent motivator for alcohol use in many individuals. However, few systematic examinations of modifiable and non-modifiable risk factors, including orofacial pain status, have been conducted. This project addresses this gap in knowledge by determining the effect of pain on drinking topography in heavy drinkers with and without chronic TMD pain in both the laboratory and daily life.

Interventions

  • DRUG alcohol condition
  • OTHER control condition

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-05-14
Est. Completion 2029-09-07
Phase Early Phase 1

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT06659991

The ClinicalTrials.gov registry entry for NCT06659991 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Temporomandibular Disorder (TMD) appearing as the primary indexed condition, and to 2 interventions - of which alcohol condition is the first listed.

NCT06659991 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT06659991 about?

NCT06659991 is a clinical study titled "JIT: Effect of Pain on DT in TMD". Individuals with chronic temporomandibular disorder (TMD) pain are at increased risk for alcohol-related consequences compared to those without pain, and growing evidence suggests pain is a potent motivator for alcohol use in many individuals. However, few systematic examinations of modifiable and n...

What is the current status of trial NCT06659991?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 160 participants. The study started on 2025-05-14. Estimated completion is 2029-09-07.

What conditions does trial NCT06659991 study?

This clinical trial studies the following conditions: Temporomandibular Disorder (TMD).

What interventions are being tested in trial NCT06659991?

The interventions under investigation include: alcohol condition (DRUG), control condition (OTHER).

Who is sponsoring clinical trial NCT06659991?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06659991 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.